Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
79 studies found for:    ctDNA
Show Display Options
Rank Status Study
1 Recruiting Circulating Tumour DNA (ctDNA) Rectal Cancer and the Relationship to Extramural Venous Invasion
Conditions: Cancer;   Rectal Cancer
Interventions: Other: Blood sample (mrEMVI positive patient);   Other: Blood sample (mrEMVI negative patient)
2 Not yet recruiting Plasma ctDNA Detection in Diagnosis of Epithelial Ovarian Cancer.
Condition: Epithelial Ovarian Cancer
Intervention: Diagnostic Test: methylation markers screening
3 Active, not recruiting Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease
Conditions: Mutation;   Neoplasms
Intervention: Genetic: ctDNA Analysis for the Detection of Genetic Mutations
4 Recruiting Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma
Condition: Adenocarcinoma of Lung (Disorder)
Intervention: Genetic: Sequencing of ctDNA in plasma
5 Recruiting Use of ctDNA for Monitoring of Stage III Colorectal Cancer
Condition: Stage III Colorectal Cancer
Intervention:
6 Recruiting ctDNA in Patients With Thyroid Nodules
Conditions: Thyroid Cancer;   Thyroid Nodules;   Thyroid Adenoma;   Thyroiditis
Intervention:
7 Active, not recruiting Plasma ctDNA in Patients Undergoing Diagnostic Colonoscopy
Conditions: Colon Cancer;   Colon Adenomas;   Colon Polyps
Intervention:
8 Recruiting Clinical Application of CTDNA in Operable Breast Cancer Patients
Condition: Breast Cancer
Interventions: Procedure: Neoadjuvant chemotherapy before surgery;   Procedure: Surgery followed by adjuvant chemotherapy
9 Not yet recruiting A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients
Condition: Triple Negative Breast Cancer
Intervention: Drug: Pembrolizumab
10 Not yet recruiting ctDNA for Prediction of Relapse in Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Other: ctDNA test
11 Not yet recruiting The Role of ctDNA, PVT1 and ROS in Diagnosis and Treatment of Gastrointestinal and Hepatobiliary Pancreatic Cancer
Condition: Neoplasms, Gastrointestinal
Intervention:
12 Active, not recruiting Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU)
Condition: Choroidal Melanoma
Intervention: Biological: Blood sampling
13 Recruiting Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention:
14 Not yet recruiting Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal Cancer
Conditions: Rectal Cancer, Adenocarcinoma;   Neoadjuvant Chemoradiation
Interventions: Drug: Capecitabine +/- Oxaliplatin;   Procedure: local resection;   Procedure: radical resection;   Other: No adjuvant chemotherapy
15 Not yet recruiting ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLC
Conditions: Non-small Cell Lung Cancer Stage III;   Non-Small-Cell Lung Cancer Metastatic;   Adenocarcinoma of Lung;   EGFR Wildtype
Intervention: Genetic: ctDNA analysis
16 Recruiting Concordance Between ctDNA Assay and FoundationOne
Conditions: Circulating Tumor DNA;   Cancer;   Neoplasms;   Genomic Testing;   Genomic Alterations
Intervention:
17 Recruiting Circulating Tumor DNA in Patients at High Risk for Lung Cancer
Conditions: Cancer of the Lung;   Lung Cancer;   Lung Neoplasms;   Adenocarcinoma of the Lung;   Non Small Cell Carcinoma of the Lung;   Small Cell Carcinoma of the Lung
Intervention:
18 Recruiting The Role of ctDNA and PBMC in Treatment of Biliary Tract Cancer
Condition: Biliary Tract Neoplasms
Intervention: Procedure: surgery or biopsy
19 Recruiting EGFR Mutations on ctDNA in Patients With Advanced NSCLC
Conditions: Non-small Cell Lung Cancer Stage III;   Non-Small-Cell Lung Cancer Metastatic
Interventions: Other: mutation detection;   Other: ARMS;   Genetic: ctDNA analysis
20 Recruiting Cambridge Liquid Biopsy and Tumour Profiling Study for Patients on Experimental Therapeutics Trials
Condition: Cancer
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.